Pleuroparenchymal Fibroelastosis in Connective Tissue Disease-Related Interstitial Lung Disease
Journal of Clinical Medicine · 10.04.2026 · 15 (8) · 2886
DOI: 10.3390/jcm15082886 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.04.2026. Verfasst von George E Dimeas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, General Hospital of Karditsa, 43100 Karditsa, Greece. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pleuroparenchymal fibroelastosis (PPFE) is a rare fibroelastotic lung disease characterized histologically by dense pleural and subpleural fibrosis with upper-lobe predominance. In clinical practice, diagnosis often relies on characteristic radiologic findings, as surgical lung biopsy is rarely feasible. Unlike idiopathic pulmonary fibrosis, robust radiologic criteria validated against biopsy-proven cohorts remain limited, and the diagnostic performance of imaging alone is incompletely defined. Although initially described as idiopathic, PPFE is increasingly recognized in secondary settings, including connective tissue disease-associated interstitial lung disease (CTD-ILD), where it frequently overlaps with more common fibrotic patterns.
Methods
We conducted a focused narrative review of the literature on PPFE in CTD-ILD, synthesizing evidence on morphology, epidemiology, clinical course, prognostic implications, and proposed pathobiological mechanisms, with emphasis on distinguishing true PPFE from PPFE-like lesions.
Results
CTD-associated PPFE is associated with accelerated lung function decline, increased risk of pneumothorax, and poorer outcomes, particularly in systemic sclerosis and rheumatoid arthritis. However, distinguishing true PPFE from radiologic mimics remains challenging, and diagnostic approaches rely heavily on imaging without robust histopathologic validation. Proposed mechanisms include epithelial injury, immune dysregulation, and vascular or lymphatic abnormalities, although causal links remain unproven. Significant gaps persist regarding natural history and therapeutic responsiveness.
Conclusions
Earlier identification of PPFE in CTD-ILD is important, as misclassification may delay risk stratification and management. Longitudinal imaging, multidisciplinary evaluation, and standardized diagnostic criteria are needed to improve clinical care and guide future research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, General Hospital of Karditsa, 43100 Karditsa, Greece.
- Department of Rheumatology, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland.
- School of Medicine, University College Dublin, D04 C1P1 Dublin, Ireland.
- Department of Respiratory Medicine, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland.
- Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece.
ORCID-Profile: Zoe Daniil, Cormac McCarthy
Zitieren
APA
Dimeas, G. E., Dimeas, I. E., Doherty, C., Molloy, E., Daniil, Z., & McCarthy, C. (2026). Pleuroparenchymal Fibroelastosis in Connective Tissue Disease-Related Interstitial Lung Disease. Journal of Clinical Medicine, 15(8), 2886. https://doi.org/10.3390/jcm15082886
Vancouver
Dimeas GE, Dimeas IE, Doherty C, Molloy E, Daniil Z, McCarthy C. Pleuroparenchymal Fibroelastosis in Connective Tissue Disease-Related Interstitial Lung Disease. Journal of Clinical Medicine. 2026;15(8):2886. doi:10.3390/jcm15082886
BibTeX
@article{Dimeas2026,
author = {Dimeas, George E and Dimeas, Ilias E and Doherty, Cathal and Molloy, Eamonn and Daniil, Zoe and McCarthy, Cormac},
title = {Pleuroparenchymal Fibroelastosis in Connective Tissue Disease-Related Interstitial Lung Disease},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {8},
pages = {2886},
doi = {10.3390/jcm15082886}
}
EUVIMED